1. To advance our understanding of the definition of surrogate end-points and its utility in clinical research.
2. To have an overview of the surrogate end-points used in PH research.
3. To analyze the validity of the PH related surrogate endpoints.
Presentation: 53 minutes
Recommended CitationRestrepo, MD, Ricardo, "Surrogate End-Points in Pulmonary Arterial Hypertension" (2013). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 89.